Human Cathepsin E (CTSE) activation kit by CRISPRa

CAT#: GA101068

CTSE CRISPRa kit - CRISPR gene activation of human cathepsin E



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Anti-CTSE Rabbit Polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


CTSE (Myc-DDK-tagged)-Human cathepsin E (CTSE), transcript variant 2
    • 10 ug

CNY 3,656.00
CNY 3,990.00


CTSE Antibody - middle region
    • 50 ug

CNY 4,628.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol CTSE
Locus ID 1510
Kit Components

GA101068G1, Cathepsin E gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA101068G2, Cathepsin E gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA101068G3, Cathepsin E gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001317331, NM_001910, NM_148964
Synonyms CATE
Summary This gene encodes a member of the A1 family of peptidases. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme, an aspartic endopeptidase, may be involved in antigen processing and the maturation of secretory proteins. Elevated expression of this gene has been observed in neurodegeneration. [provided by RefSeq, Nov 2015]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...